Should Patients with Crohn's Disease be in Colonoscopic Surveillance Programs?

被引:0
|
作者
Lashner, Bret A. [1 ]
机构
[1] Cleveland Clin, Ctr Inflammatory Bowel Dis, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA
关键词
D O I
10.1002/ibd.20595
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:S192 / S193
页数:2
相关论文
共 50 条
  • [41] Should Immunomodulation Therapy Alter the Surgical Management in Patients With Rectovaginal Fistula and Crohn's Disease?
    Narang, Rahul
    Hull, Tracy
    Perrins, Steven
    Garcia, Jose Sebastian
    Wexner, Steven D.
    DISEASES OF THE COLON & RECTUM, 2016, 59 (07) : 670 - 676
  • [42] Determination of Bone Age in Pediatric Patients With Crohn's Disease Should Be a Part of Routine Care
    Gupta, Neera
    Lustig, Robert H.
    Kohn, Michael
    Vittinghoff, Eric
    GASTROENTEROLOGY, 2012, 142 (05) : S372 - S372
  • [43] Comparable Short- and Long-term Outcomes of Colonoscopic Balloon Dilation of Crohn's Disease and Benign Non-Crohn's Disease Strictures
    Chen, Min
    Shen, Bo
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (10) : 1739 - 1746
  • [44] Should azathioprine be withdrawn in patients with Crohn's disease who are in long-term remission?
    Sandro Ardizzone
    Gabriele Bianchi Porro
    Nature Clinical Practice Gastroenterology & Hepatology, 2005, 2 : 348 - 349
  • [45] Should azathioprine be withdrawn in patients with Crohn's disease who are in long-term remission?
    Ardizzone, S
    Porro, GB
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2005, 2 (08): : 348 - 349
  • [46] LONG-TERM SAFETY AND OUTCOMES OF COLONOSCOPIC BALLOON DILATION FOR STRICTURING CROHN'S DISEASE
    Alghamdi, Waleed S.
    Chande, Nilesh
    Khanna, Nitin
    Gregor, James C.
    GASTROENTEROLOGY, 2019, 156 (06) : S447 - S447
  • [47] Crohn's colitis versus ulcerative colitis: should surveillance for dysplasia and cancer differ?
    Korelitz, Burton I.
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2009, 6 (03): : 144 - 145
  • [48] Crohn's colitis versus ulcerative colitis: should surveillance for dysplasia and cancer differ?
    Burton I Korelitz
    Nature Reviews Gastroenterology & Hepatology, 2009, 6 : 144 - 145
  • [49] Risankizumab in patients with Crohn's disease
    Blumenstein, Irina
    Nitschmann, Sirka
    INNERE MEDIZIN, 2023, 64 (01): : 102 - 106
  • [50] Polypharmacy in Patients With Crohn's Disease
    Yu, Huimin
    Foley, Sarah E.
    Crocker, Justin A.
    Tuskey, Anne G.
    Behm, Brian W.
    GASTROENTEROLOGY, 2014, 146 (05) : S445 - S446